#AAN2018- Inbrija Reduces Parkinson’s Off Periods, Phase 3 Trial Shows
News
Inbrija reduces Parkinson’s symptoms when standard treatments wear off, and decreases the length of these off periods, a Phase 3 clinical trial shows. The therapy’s developer, Acorda Therapeutics, will present the results ... Read more